Yüklüyor......
Screening for Prostate Cancer: Early Detection or Overdetection?
A sophisticated reading of the randomized trial evidence suggests that, although screening for prostate cancer with prostate-specific antigen (PSA) can reduce cancer-specific mortality, it does so at considerable cost in terms of the number of men who need to be screened, biopsied, and treated to pr...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3415315/ https://ncbi.nlm.nih.gov/pubmed/22053739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-med-050710-134421 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|